Samar Alshawwa Honored with Excellence in Research Award for Contributions to Drug-Induced Research

 

Advancing Biomedical Knowledge Through Scholarly Excellence

Research and innovation continue to shape the future of global healthcare, pharmaceutical sciences, and biomedical discovery. Among the distinguished researchers contributing to this progress is Samar Alshawwa, whose academic achievements have earned recognition through the Excellence in Research Award presented at the International Cognitive Scientists Award.

Affiliated with Princess Nourah bint Abdulrahman University in Saudi Arabia, Samar Alshawwa has established a strong scholarly presence within the field of Drug-Induced research. Through extensive publication activity, impactful scientific collaboration, and measurable citation influence, the researcher has contributed significantly to the advancement of biomedical and pharmaceutical sciences.

          


Academic Profile and Research Recognition

Academic excellence is often evaluated through scholarly productivity, research visibility, and citation performance. According to indexed academic records, Samar Alshawwa maintains an impressive research portfolio featuring:

  • 63 indexed scholarly documents

  • 1,563 citations

  • h-index of 21

  • Active research engagement in Drug-Induced studies

These indicators reflect sustained academic contributions and continuing influence within international scientific literature. The recognition associated with the Excellence in Research Award highlights the importance of evidence-based scholarship and interdisciplinary scientific inquiry in contemporary healthcare research.

Contributions to Drug-Induced Research

Drug-induced research plays a vital role in understanding the biological, pharmacological, and clinical effects associated with therapeutic compounds and pharmaceutical interventions. Research within this field contributes to safer drug development, improved treatment methodologies, and enhanced patient care outcomes.

The scholarly work associated with Samar Alshawwa focuses on scientific investigation into pharmacological mechanisms, biomedical responses, and clinically relevant research methodologies. Through peer-reviewed publications and collaborative scientific studies, the research contributes to expanding current knowledge related to drug interactions, therapeutic effectiveness, and biomedical innovation.

Such contributions are essential for strengthening healthcare systems and supporting future advancements in pharmaceutical sciences.

Publication Record and Scholarly Communication

A strong publication portfolio remains one of the most visible indicators of academic impact. The researcher’s indexed works demonstrate continued engagement with contemporary scientific challenges and evolving biomedical questions.

Through publication in recognized academic journals and participation in collaborative research initiatives, Samar Alshawwa has contributed to scholarly communication and international knowledge dissemination. These research outputs support academic dialogue while also influencing future investigations within related scientific domains.

The measurable citation activity associated with the researcher’s publications further indicates the relevance and applicability of the work within broader scientific communities.

Measuring Research Impact

Research influence extends beyond publication volume and includes the degree to which scholarly findings inform future studies, policy discussions, and scientific innovation. Citation metrics and author impact indicators provide insight into the visibility and utilization of academic contributions.

With more than one thousand citations and a strong h-index score, Samar Alshawwa demonstrates meaningful research influence within the biomedical and pharmaceutical research landscape. Such academic visibility reflects the continued relevance of the researcher’s work and the importance of sustained scientific engagement.

The recognition through the Excellence in Research Award aligns with international academic standards used to acknowledge impactful research contributions and scholarly leadership.

International Academic Recognition

The International Cognitive Scientists Award recognizes researchers whose work demonstrates scientific rigor, interdisciplinary excellence, and measurable scholarly influence. Recipients are often distinguished by publication performance, citation impact, research innovation, and contributions to global academic advancement.

The recognition awarded to Samar Alshawwa reflects both individual scholarly achievement and the growing international visibility of research contributions emerging from Saudi Arabian academic institutions. It also reinforces the significance of collaborative and evidence-driven scientific inquiry in addressing modern healthcare challenges.

Future Research Outlook

As biomedical sciences continue to evolve, research focused on drug-induced mechanisms and pharmacological responses remains increasingly important. Ongoing advancements in healthcare technologies, precision medicine, and therapeutic innovation will continue to rely heavily on rigorous scientific investigation.

The academic profile of Samar Alshawwa demonstrates the qualities associated with sustained research excellence, including publication consistency, scholarly impact, and interdisciplinary contribution. Continued engagement in scientific research is expected to further enhance both academic influence and practical applications within healthcare and pharmaceutical sciences.

Conclusion

The Excellence in Research Award awarded to Samar Alshawwa recognizes a distinguished academic profile marked by publication productivity, citation influence, and contributions to Drug-Induced research. Through scholarly communication, collaborative scientific inquiry, and measurable research impact, the researcher has established a respected presence within the international biomedical research community.

As scientific innovation continues to shape the future of healthcare and pharmacology, researchers such as Samar Alshawwa play an important role in advancing knowledge, supporting evidence-based practice, and contributing to global scientific progress.

External Profiles and References

Meta Information

Focus Keyword: Samar Alshawwa Excellence in Research Award
Secondary Keyword: Drug-Induced Research Scientist
Meta Keywords: Samar Alshawwa, Excellence in Research Award, Drug-Induced Research
Meta Description: Samar Alshawwa of Princess Nourah bint Abdulrahman University receives the Excellence in Research Award for impactful contributions to Drug-Induced research, biomedical sciences, and scholarly innovation.

 28th Edition of International Cognitive scientist Awards | 28–29 June 2026

The International Cognitive Scientist Awards is a prestigious global platform dedicated to recognizing outstanding contributions in cognitive science, neuroscience, psychology, artificial intelligence, brain research, and human intelligence studies. connect Here :----------- Visit our website: cognitivescientist.org Nomination now: cognitivescientist.org/award-nomination/?ecategory=Awards&rcategory=Awardeecontact@cognitivescientist.org #CognitiveScienceAwards #InternationalAwards #CognitiveScience #CognitiveResearch #InnovationInScience #GlobalScienceCommunity #ResearchExcellence #CognitiveInnovation #AwardCeremony #ScienceCelebration #CognitiveScientists


Comments

Post a Comment

Popular posts from this blog

As fewer Americans die from heart attacks, more succumb to chronic heart disease

Image
  From 1970 to 2022, deaths from heart attacks dropped by almost 90%, but more Americans now die from other types of heart disease, Stanford Medicine-led research has found. In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving the hospital alive. Today, the survival rate is over 90%, with even better outcomes for younger patients. Those numbers have contributed to a remarkable decrease in the likelihood of dying from any type of heart disease over the last 50 years, according to a new study of heart disease mortality led by Stanford Medicine researchers. In 1970, 41% of all deaths were attributed to ailments of the heart; in 2022, that statistic had dropped to 24% of all deaths.  Most strikingly, the proportion of deaths from acute myocardial infarctions — commonly known as heart attacks — fell nearly 90% during that period. The decrease is a testament to the leaps and bounds made in our ability to manage an...
Read more

Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association

Image
  Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias. Sleep disorders such as sleep-disordered breathing (eg, obstructive sleep apnea), and other sleep disturbances, as well, some of which are also considered sleep disorders (eg, insomnia, sleep fragmentation, circadian rhythm disorders, and extreme sleep duration), have been associated with adverse brain health.  Understanding the causal role of sleep disorders and disturbances in the development of adverse brain health is complicated by the common development of sleep disorders among individuals with neurodegenerative disease. In addition to the role of sleep disorders in stroke and cerebrovascular injury, mechanistic hypotheses linking sleep with brain health and biomarker data (blood-based, cerebrospina...
Read more

Cycling Boosts Brain Function in Parkinson’s Disease

Image
A novel study conducted at University Hospitals and the VA Northeast Ohio Healthcare System, through its Cleveland Functional Electrical Stimulation (FES) Center, provides clues, as it shows that long-term dynamic exercise programs might have wider restorative effects on the brain signals of Parkinson’s Disease (PD) patients than researchers previously thought. Researchers used recordings from participants’ deep brain stimulation devices to try to assess how long-term exercise programs might be re-activating connections damaged by Parkinson’s Disease. Unlike previous studies, this investigation sought to decode the brain changes linked to motor symptom relief; both with the help of second-generation DBS devices and a long-term dynamic cycling exercise regimen in Parkinson’s patients. Details on the study are published in the June 2025 issue of  Clinical Neurophysiology . The pilot investigation, funded by a VA Merit Award from the Department of Veterans Affairs along with philanthr...
Read more